News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple L.A. McKeown December 09, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Daily News Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic Yael L. Maxwell November 15, 2024
News Daily News SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients L.A. McKeown October 23, 2024
News Features Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts Michael O'Riordan October 21, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome Caitlin E. Cox October 04, 2024
News Daily News Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits Michael O'Riordan October 03, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Opinion Editor's Corner Olympic Hearts: Screening for CVD Among Team USA’s Athletes Michael O'Riordan July 31, 2024
News Daily News Schoolwide Intervention May Improve Obesity Outcomes Over Time Yael L. Maxwell July 29, 2024
News Conference News SCCT 2024 Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients Todd Neale July 22, 2024
News Daily News Think You Need a Statin? AHA’s Risk Calculator May Disagree Michael O'Riordan June 28, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024